Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 7Gastrointestinal 2Lymphoid 1

Conditions

Thrombocytopenia 1Jacobs syndrome 1Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × avatrombopag × Gastrointestinal × Clear all
NCT05772546 2026-03-13

ACT-GI

Massachusetts General Hospital

Phase 2 Active not recruiting
60 enrolled
Gastrointestinal

Jacobs syndrome, Gastrointestinal Neoplasms

NCT06001567 2023-09-14

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Second Affiliated Hospital of Guangzhou Medical University

Phase 2 Unknown
30 enrolled
Classical hematologyGastrointestinal

Carcinoma, Hepatocellular, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡